RESUMO
OBJECTIVE: Smokers who switch to "lighter" cigarettes may be diverted from quitting smoking. We assessed factors associated with switching and the association between switching and (1) making a quit attempt, and (2) recent quitting, yielding a measure of net quitting (attempts x recent quitting). DESIGN: In 2003, a total of 30 800 ever-smokers who smoked in the past year provided history of switching and 3 reasons for switching: harm reduction, quitting smoking and flavour. Among those who made a past-year quit attempt, recent quitting was defined as >or=90-day abstinence when surveyed. Multivariable logistic regression identified determinants of outcomes. RESULTS: In all, 12 009 (38%) of ever-smokers switched. Among switchers, the most commonly cited reasons were flavour only (26%) and all 3 reasons (18%). Switchers (vs non-switchers) were more likely to make a quit attempt between 2002 and 2003 (51% vs 41%, p<0.001, adjusted odds ratio (AOR) 1.58, (95% confidence interval (CI) 1.48 to 1.69)), but less likely to have recently quit (9% vs 17%, p<0.001; AOR 0.40 (95% CI 0.35 to 0.45)), yielding lower overall net quitting (4.3% vs 7.0%, p<0.001; AOR 0.54, (95% CI 0.47 to 0.61)). The effects of switching on outcomes were most pronounced for reasons including quitting smoking, whereas switching for harm reduction alone had no association with outcomes. CONCLUSION: Compared with no switching, a history of switching was associated with 46% lower odds of net quitting.
Assuntos
Abandono do Hábito de Fumar/estatística & dados numéricos , Prevenção do Hábito de Fumar , Adolescente , Adulto , Fatores Etários , Escolaridade , Feminino , Redução do Dano , Humanos , Masculino , Pessoa de Meia-Idade , Fatores Sexuais , Fumar/efeitos adversos , Fumar/epidemiologia , Estados Unidos/epidemiologia , Adulto JovemRESUMO
BACKGROUND: Cigarette smoking is responsible for at least one third of all cancer deaths annually in the United States. Few sources exist in the peer-reviewed literature documenting state and regional differences in smoking behavior, despite the fact that cancer prevention and control efforts are increasingly being implemented below the national level. PURPOSE: Our goals were to determine smoking prevalence rates among men and women, by region, and for each of the 50 states and the District of Columbia from census survey data collected in 1992 and 1993 and to compare these rates with rates determined in 1985. METHODS: Every month, the U.S. Bureau of the Census collects labor force statistics on more than 100000 individuals on its Current Population Survey (CPS). For the September 1992, January 1993, and May 1993 CPS, the National Cancer Institute sponsored a 40-item Tobacco Use Supplement. The definition of a current smoker changed slightly between 1985 and 1992-1993. For the 1985 CPS, individuals were considered current smokers if they had smoked 100 cigarettes in their lifetime and were smoking at the time of interview; for the 1992-1993 CPS, current smokers included anyone who had smoked 100 cigarettes and was currently smoking every day or just on some days. We calculated current smoking rates (every day and some days combined) based on more than a quarter million adults (n = 266988) interviewed in 1992-1993. RESULTS: Substantial geographic variation exists in rates of current cigarette use among adults within the United States. In general, adults in the southern United States have higher rates of smoking and adults in the western states have lower rates of smoking and adults in the rest of the country, although differences in smoking behavior between men and women and among various racial and ethnic populations strongly influence these patterns. Only two states, Kentucky and West Virginia, exhibited adult smoking rates (men and women combined) of 30% or higher in 1992-1993; in contrast, in 1985, such rates were reported from 20 states. The only states in which the prevalence was below 20% in 1992-1993 were Utah (17.1%) and California (19.5%). Rates approaching 20% were reported from New Jersey (20.7%), Massachusetts (21.5%), and Nebraska, New York, and Hawaii (22.0% each) in 1992-1993. Rhode Island experienced the greatest relative decline in smoking prevalence from 1985 to 1992-1993, with a calculated relative change of -30.7% (based on a change in rate from 33.5% to 23.2%), followed by Delaware (-25.9%) the District of Columbia and New Jersey (-23.9% each), Connecticut (-23.2%), California (-22.9%), Alaska (-22.8%), Georgia (-22.6%), Massachusetts (-22.1%), and New York (-22.0%). CONCLUSIONS: Smoking rates are not uniform in the United States but vary considerably from state to state, even within the same region of the country. The CPS is the only mechanism currently capable of simultaneously monitoring smoking trends nationally, regionally, and on a state-by-state basis.
Assuntos
Fumar/epidemiologia , Distribuição por Idade , Etnicidade/estatística & dados numéricos , Feminino , Humanos , Masculino , Ocupações/estatística & dados numéricos , Vigilância da População , Prevalência , Distribuição por Sexo , Fumar/etnologia , Estados Unidos/epidemiologiaRESUMO
BACKGROUND: High-dose isotretinoin has been reported to have a prophylactic effect on nonmelanoma skin cancer, although it is associated with significant toxicity. PURPOSE: To test the effectiveness of the long-term administration of low-dose isotretinoin in reducing the occurrence of basal cell carcinoma at a new site in patients with previously treated basal cell carcinomas and to measure the toxicity associated with this regimen, we conducted a clinical trial at eight cancer centers. METHODS: Nine hundred and eighty-one patients with two or more previously confirmed basal cell carcinomas were randomly assigned to receive either 10 mg of isotretinoin or a placebo daily. Patients were followed for 36 months and monitored at 6-month intervals for skin cancer and toxic effects. RESULTS: After 36 months of treatment, no statistically significant difference in either the cumulative percent of patients with an occurrence of basal cell carcinoma at a new site or the annual rate of basal cell carcinoma formation existed between patients receiving isotretinoin and those receiving the placebo. Elevated serum triglycerides, hyperostotic axial skeletal changes, and mucocutaneous reactions were more frequent in the group receiving isotretinoin than in the control group, and these differences were all statistically significant (P less than .001). CONCLUSION: This low-dose regimen of isotretinoin not only is ineffective in reducing the occurrence of basal cell carcinoma at new sites in patients with two or more previously treated basal cell carcinomas but also is associated with significant adverse systemic effects. IMPLICATION: The toxicity associated with the long-term administration of isotretinoin, even at the low dose used in this trial, must be weighted in planning future prevention trials.
Assuntos
Anticarcinógenos/uso terapêutico , Carcinoma Basocelular/prevenção & controle , Isotretinoína/uso terapêutico , Neoplasias Cutâneas/prevenção & controle , Idoso , Anticarcinógenos/administração & dosagem , Anticarcinógenos/efeitos adversos , Feminino , Humanos , Isotretinoína/administração & dosagem , Isotretinoína/efeitos adversos , Masculino , Pessoa de Meia-IdadeRESUMO
BACKGROUND: Epidemiologic studies have suggested that vitamin E and beta-carotene may each influence the development of prostate cancer. In the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a controlled trial, we studied the effect of alpha-tocopherol (a form of vitamin E) and beta-carotene supplementation, separately or together, on prostate cancer in male smokers. METHODS: A total of 29133 male smokers aged 50-69 years from southwestern Finland were randomly assigned to receive alpha-tocopherol (50 mg), beta-carotene (20 mg), both agents, or placebo daily for 5-8 years (median, 6.1 years). The supplementation effects were estimated by a proportional hazards model, and two-sided P values were calculated. RESULTS: We found 246 new cases of and 62 deaths from prostate cancer during the follow-up period. A 32% decrease (95% confidence interval [CI] = -47% to -12%) in the incidence of prostate cancer was observed among the subjects receiving alpha-tocopherol (n = 14564) compared with those not receiving it (n = 14569). The reduction was evident in clinical prostate cancer but not in latent cancer. Mortality from prostate cancer was 41% lower (95% CI = -65% to -1%) among men receiving alpha-tocopherol. Among subjects receiving beta-carotene (n = 14560), prostate cancer incidence was 23% higher (95% CI = -4%-59%) and mortality was 15% higher (95% CI = -30%-89%) compared with those not receiving it (n = 14573). Neither agent had any effect on the time interval between diagnosis and death. CONCLUSIONS: Long-term supplementation with alpha-tocopherol substantially reduced prostate cancer incidence and mortality in male smokers. Other controlled trials are required to confirm the findings.
Assuntos
Anticarcinógenos/uso terapêutico , Neoplasias da Próstata/epidemiologia , Neoplasias da Próstata/prevenção & controle , Vitamina E/uso terapêutico , beta Caroteno/uso terapêutico , Método Duplo-Cego , Humanos , Incidência , Masculino , Neoplasias da Próstata/mortalidade , Resultado do TratamentoRESUMO
BACKGROUND: Experimental and epidemiologic investigations suggest that alpha-tocopherol (the most prevalent chemical form of vitamin E found in vegetable oils, seeds, grains, nuts, and other foods) and beta-carotene (a plant pigment and major precursor of vitamin A found in many yellow, orange, and dark-green, leafy vegetables and some fruit) might reduce the risk of cancer, particularly lung cancer. The initial findings of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study) indicated, however, that lung cancer incidence was increased among participants who received beta-carotene as a supplement. Similar results were recently reported by the Beta-Carotene and Retinol Efficacy Trial (CARET), which tested a combination of beta-carotene and vitamin A. PURPOSE: We examined the effects of alpha-tocopherol and beta-carotene supplementation on the incidence of lung cancer across subgroups of participants in the ATBC Study defined by base-line characteristics (e.g., age, number of cigarettes smoked, dietary or serum vitamin status, and alcohol consumption), by study compliance, and in relation to clinical factors, such as disease stage and histologic type. Our primary purpose was to determine whether the pattern of intervention effects across subgroups could facilitate further interpretation of the main ATBC Study results and shed light on potential mechanisms of action and relevance to other populations. METHODS: A total of 29,133 men aged 50-69 years who smoked five or more cigarettes daily were randomly assigned to receive alpha-tocopherol (50 mg), beta-carotene (20 mg), alpha-tocopherol and beta-carotene, or a placebo daily for 5-8 years (median, 6.1 years). Data regarding smoking and other risk factors for lung cancer and dietary factors were obtained at study entry, along with measurements of serum levels of alpha-tocopherol and beta-carotene. Incident cases of lung cancer (n = 894) were identified through the Finnish Cancer Registry and death certificates. Each lung cancer diagnosis was independently confirmed, and histology or cytology was available for 94% of the cases. Intervention effects were evaluated by use of survival analysis and proportional hazards models. All P values were derived from two-sided statistical tests. RESULTS: No overall effect was observed for lung cancer from alpha-tocopherol supplementation (relative risk [RR] = 0.99; 95% confidence interval [CI] = 0.87-1.13; P = .86, logrank test). beta-Carotene supplementation was associated with increased lung cancer risk (RR = 1.16; 95% CI = 1.02-1.33; P = .02, logrank test). The beta-carotene effect appeared stronger, but not substantially different, in participants who smoked at least 20 cigarettes daily (RR = 1.25; 95% CI = 1.07-1.46) compared with those who smoked five to 19 cigarettes daily (RR = 0.97; 95% CI = 0.76-1.23) and in those with a higher alcohol intake (> or = 11 g of ethanol/day [just under one drink per day]; RR = 1.35; 95% CI = 1.01-1.81) compared with those with a lower intake (RR = 1.03; 95% CI = 0.85-1.24). CONCLUSIONS: Supplementation with alpha-tocopherol or beta-carotene does not prevent lung cancer in older men who smoke. beta-Carotene supplementation at pharmacologic levels may modestly increase lung cancer incidence in cigarette smokers, and this effect may be associated with heavier smoking and higher alcohol intake. IMPLICATIONS: While the most direct way to reduce lung cancer risk is not to smoke tobacco, smokers should avoid high-dose beta-carotene supplementation.
Assuntos
Antioxidantes/uso terapêutico , Neoplasias Pulmonares/prevenção & controle , Vitamina E/uso terapêutico , beta Caroteno/uso terapêutico , Fatores Etários , Idoso , Consumo de Bebidas Alcoólicas/efeitos adversos , Anticarcinógenos/uso terapêutico , Carcinógenos/efeitos adversos , Alimentos Fortificados , Humanos , Incidência , Neoplasias Pulmonares/sangue , Neoplasias Pulmonares/etiologia , Neoplasias Pulmonares/mortalidade , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Cooperação do Paciente , Modelos de Riscos Proporcionais , Risco , Fatores de Risco , Fumar/efeitos adversos , Vitamina E/sangue , beta Caroteno/sangueRESUMO
Numerous factors affect the reproducibility and validity of dietary assessment questionnaires. Although the respondents' abilities to respond accurately are most frequently discussed as the cause of apparently poor reproducibility and validity, many other factors are as important and perhaps more important. Most of these other factors are under the control of the investigator, and thus are amenable to improvement. Factors which may affect reproducibility included the degree of variability permitted by the instrument, the error-proneness of the response format, quality control of coding and keying and real dietary change in the time between the two administrations of the questionnaire. Factors affecting real or apparent validity include respondent characteristics, questionnaire design and quantification, quality control, and the adequacy of the reference data. The implications of inadequate reference data are illustrated and discussed.
Assuntos
Avaliação Nutricional , Humanos , Controle de Qualidade , Padrões de Referência , Reprodutibilidade dos Testes , Inquéritos e Questionários/normasRESUMO
The Alpha-Tocopherol Beta-Carotene (ATBC) Cancer Prevention Study was a placebo-controlled, randomized intervention trial testing the hypothesis that beta-carotene and alpha-tocopherol (vitamin E) supplements prevent lung and other cancers. The study is predicated on a substantial body of evidence supporting a role in cancer prevention for these micronutrients. Based on the 2 x 2 factorial study design, 29,133 eligible male cigarette smokers aged 50-69 y were randomly assigned to receive beta-carotene (20 mg), alpha-tocopherol (50 mg), beta-carotene and alpha-tocopherol, or placebo daily for 5-8 y. Capsule compliance was high (median = 99%). beta-Carotene treatment did not result in a decrease in cancer at any of the major sites but rather in an increase at several sites, most notably lung, prostate, and stomach (number of cases 474 compared with 402, 138 compared with 112, and 70 compared with 56, respectively). The vitamin E group had fewer incident cancers of the prostate and colorectum compared with the group not receiving vitamin E (number of cases 99 compared with 151 and 68 compared with 81, respectively), but more cancers of the stomach (70 compared with 56). In contrast to these intervention-based findings for beta-carotene and vitamin E supplements, we observed lower lung cancer rates in men with higher amounts of both serum and dietary beta-carotene and vitamin E at baseline.
Assuntos
Antioxidantes/administração & dosagem , Carotenoides/administração & dosagem , Neoplasias/prevenção & controle , Vitamina E/administração & dosagem , Idoso , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Neoplasias/epidemiologia , Fumar/efeitos adversos , beta CarotenoRESUMO
Adverse effects associated with the long-term low-dose regimens of retinoids used in cancer chemoprevention studies are not well described. In order to examine the clinical and laboratory adverse effects of 3 years of intervention with isotretinoin (10 mg/day) and to assess potential risk factors for developing these, we collected adverse effect data on patients participating in a randomized, placebo-controlled trial designed to evaluate the effectiveness of isotretinoin in preventing the subsequent occurrence of new basal cell carcinoma. Our results showed a significantly higher incidence of adverse mucocutaneous effects and serum triglyceride elevations in the isotretinoin group (P < 0.001). Associated risk factors included male gender, very fair skin, and elevated pretreatment triglyceride levels. The toxicity observed, although less severe and less frequent, was similar to that seen with higher doses and should be weighed with adverse skeletal effects when considering long-term treatment of patients with moderate cancer risk.
Assuntos
Carcinoma Basocelular/prevenção & controle , Isotretinoína/efeitos adversos , Neoplasias Cutâneas/prevenção & controle , Adulto , Idoso , Queilite/induzido quimicamente , Colesterol/sangue , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Hipercolesterolemia/induzido quimicamente , Hipertrigliceridemia/induzido quimicamente , Incidência , Isotretinoína/administração & dosagem , Isotretinoína/uso terapêutico , Articulações/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Músculos/efeitos dos fármacos , Dor , Placebos , Fatores de Risco , Pele/patologia , Triglicerídeos/sangueRESUMO
The association between prostate cancer and baseline vitamin E and selenium was evaluated in the trial-based cohort of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (n = 29,133). During up to 9 years of follow-up, 317 men developed incident prostate cancer. Multivariate Cox proportional hazards models that adjusted for intervention group, benign prostatic hyperplasia, age, smoking, and urban residence were used to evaluate associations between prostate cancer and exposures of interest. There were no significant associations between baseline serum alpha-tocopherol, dietary vitamin E, or selenium and prostate cancer overall. The associations between prostate cancer and vitamin E and some of the baseline dietary tocopherols differed significantly by alpha-tocopherol intervention status, with the suggestion of a protective effect for total vitamin E among those who received the alpha-tocopherol intervention (relative risk was 1.00, 0.68, 0.80, and 0.52 for increasing quartiles; P = 0.07).
Assuntos
Neoplasias da Próstata/prevenção & controle , Selênio/sangue , Vitamina E/sangue , beta Caroteno/sangue , Idoso , Suplementos Nutricionais , Método Duplo-Cego , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/sangue , Selênio/administração & dosagem , Fumar , Vitamina E/administração & dosagem , beta Caroteno/administração & dosagemRESUMO
BACKGROUND AND DESIGN: We conducted a prospective roentgenographic survey of patients participating in a randomized, placebo-controlled, multicenter clinical trial that evaluated the effectiveness of chronic, very-low-dose (approximately 0.14 mg/kg per day for 3 years) isotretinoin in preventing the subsequent occurrences of new basal cell carcinoma in patients with previous basal cell carcinoma. To assess potential skeletal changes, a sample of 269 patients from among a total of 981 enrollees were randomly selected for comparative roentgenographic review. Baseline and 36-month roentgenograms of the cervical and thoracic spine of each patient were read side by side by a radiologist, masked to treatment group, who noted both the presence and extent of abnormalities at each vertebral level at baseline and the progression of existing or occurrence of new abnormalities at previously unaffected levels at 36 months. RESULTS: In comparison with the placebo group, significantly more patients in the isotretinoin group exhibited progression of existing hyperostotic abnormalities (40% vs 18%; P less than .001) and new hyperostotic involvement at previously unaffected vertebral levels (8% vs 1%; P = .015). CONCLUSION: Our findings indicate that chronic, very-low-dose isotretinoin can induce hyperostotic axial skeletal changes similar to those reported in patients taking higher doses.
Assuntos
Hiperostose Esquelética Difusa Idiopática/induzido quimicamente , Isotretinoína/efeitos adversos , Adulto , Idoso , Carcinoma Basocelular/prevenção & controle , Vértebras Cervicais/diagnóstico por imagem , Feminino , Humanos , Hiperostose Esquelética Difusa Idiopática/diagnóstico por imagem , Isotretinoína/administração & dosagem , Isotretinoína/uso terapêutico , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/prevenção & controle , Estudos Prospectivos , Radiografia , Neoplasias Cutâneas/prevenção & controle , Vértebras Torácicas/diagnóstico por imagemRESUMO
OBJECTIVE: To examine the effect of alpha tocopherol and beta carotene supplementation on the incidence of age related cataract extraction. SETTING: The Alpha-tocopherol Beta-carotene (ATBC) Study was a randomised, double blind, placebo controlled, 2 x 2 factorial trial conducted in south western Finland. The cataract surgery study population of 28,934 male smokers 50-69 years of age at the start. INTERVENTION: Random assignment to one of four regimens: alpha tocopherol 50 mg per day, beta carotene 20 mg per day, both alpha tocopherol and beta carotene, or placebo. Follow up continued for five to eight years (median 5.7 years) with a total of 159,199 person years. OUTCOME MEASURE: Cataract extraction, ascertained from the National Hospital Discharge Registry. RESULTS: 425 men had cataract surgery because of senile or presenile cataract during the follow up. Of these, 112 men were in the alpha tocopherol alone group, 112 men in the beta carotene alone group, 96 men in the alpha tocopherol and beta carotene group, and 105 men in the placebo group. When supplementation with alpha tocopherol and with beta carotene were introduced to a Cox proportional hazards model with baseline characteristics (age, education, history of diabetes, body mass index, alcohol consumption, number of cigarettes smoked daily, smoking duration, visual acuity, and total cholesterol), neither alpha tocopherol (relative risk, RR, 0.91, 95% confidence intervals, CI, 0.74, 1.11) nor beta carotene (RR 0.97, 95% CI 0.79, 1.19) supplementation affected the incidence of cataract surgery. CONCLUSION: Supplementation with alpha tocopherol or beta carotene does not affect the incidence of cataract extractions among male smokers.
Assuntos
Extração de Catarata , Catarata/prevenção & controle , Fumar/efeitos adversos , Vitamina E/uso terapêutico , beta Caroteno/uso terapêutico , Idoso , Método Duplo-Cego , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais , Risco , Falha de TratamentoRESUMO
The effect of the number of diet records used as the reference data on the apparent validity of a diet history questionnaire was examined using data from 97 participants in the Women's Health Trial feasibility study. Pearson correlation coefficients were computed between the estimates of usual individual intake from the questionnaire and estimates from the mean of three 4-day records obtained over a 1-year period, the mean of the two most recent records, and the record obtained 1 year after the start of the study. The results illustrate that the apparent validity of a questionnaire increases when it is compared with a greater number of 4-day food records. The correlations increased for most nutrients when the baseline food record was included, despite the fact that it was completed at a time not targeted by the questionnaire. These findings suggest that greater effort should be given to obtaining more diet-record days when validating other dietary assessment instruments.
Assuntos
Registros de Dieta , Inquéritos e Questionários , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Distribuição Aleatória , Reprodutibilidade dos TestesRESUMO
The validity of two dietary history questionnaires was examined, one the Health Habits and History Questionnaire (HHHQ) developed by Block et al and the other a questionnaire developed by investigators at the University of Michigan (UM). The reference data consisted of the mean of four 4-day dietary records and recalls collected for 1 year before administration of the questionnaires. The sample of 85 persons included black and white men and women aged 25 to 50 years. The HHHQ was entirely self-administered; the UM questionnaire had both self- and interviewer-administered components. The HHHQ group means were similar to food record estimates for energy and most nutrients, whereas the UM questionnaire produced overestimates for energy and all nutrients examined. Correlations ranged from .31 to .60 (median = .48) for the UM questionnaire and from .42 to .68 (median = .57) for the HHHQ. Use of respondent-reported portion sizes with the HHHQ produced higher correlations than use of investigator-determined "standard" portion sizes (median r = .43 vs .57). Food frequency questionnaires can provide useful nutrient data for individuals as well as groups.
Assuntos
Registros de Dieta , Ingestão de Alimentos , Inquéritos e Questionários , Adulto , Algoritmos , Ingestão de Energia , Feminino , Comportamentos Relacionados com a Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos TestesRESUMO
We examined trends in smoke-free workplace policies among all indoor workers in the United States using the National Cancer Institute's Tobacco Use Supplement to the Census Bureau's Current Population Survey (total n = 270,063). Smoke-free was defined as smoking not permitted in public or common areas or in work areas of a worksite. Nationally, we found that nearly 70% of the US workforce worked under a smoke-free policy in 1999. At the state level, a greater than 30-percentage-point differential existed in the proportion of workers with such policies. Although significant progress has been made to reduce worker exposure to environmental tobacco smoke on the job, we predict further progress may be difficult unless comprehensive regulations to protect all workers are implemented at the national, state, or local level.
Assuntos
Poluição por Fumaça de Tabaco/legislação & jurisprudência , Poluição por Fumaça de Tabaco/prevenção & controle , Local de Trabalho/legislação & jurisprudência , Adolescente , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estados UnidosRESUMO
To answer questions raised about the accuracy of temporal intervals used to produce perception of apparent motion, interstimulus intervals generated by a computer were measured using physical and psychophysical procedures. Calibration of such devices was assumed initially to be routine but search of the literature indicated that calibration has been ignored in studies of motion and masking. Direct/physical methods of calibration proved unfeasible for assessing the accuracy of a computer programmed through "poke" procedures because signals for temporal intervals could not be differentiated from the output controlled by the machine's "hardwired" program. The results of psychophysical measurement of temporal intervals indicated that, on the average, differences, "constant errors" between expected/programmed intervals and matches of those intervals generally were less than six milliseconds.
Assuntos
Microcomputadores , Software , Percepção do Tempo , Adolescente , Adulto , Calibragem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Percepção de Movimento , Ilusões Ópticas , Reconhecimento Visual de Modelos , PsicofísicaRESUMO
The experiments reported here show that Korte's space-time invariance equation governing perception of apparent motion is limited to situations in which metric or apparent separation of targets define but a single interval of space. Variation in interstimulus intervals and metric separation of targets did not influence the perception of apparent motion when the background array was structured to depict apparently equal intervals of space. These results provide a test of Koffka's and more recently Gibson's view that higher order properties of intervals of space specify the spatial factor in apparent movement.
Assuntos
Percepção de Movimento , Percepção Espacial , Adulto , Percepção de Profundidade , Aprendizagem por Discriminação , Percepção de Distância , Feminino , Humanos , Masculino , Ilusões ÓpticasRESUMO
Prior to the 1930s, designs of research into sexual behavior of infrahuman primates were not comparable; conclusions about physiological and nonphysiological factors in receptivity and mating were confounded by species studied, living and testing conditions, and precaptivity history. Clearly there was need for comprehensive and controlled studies of infrahuman primate sexual behavior. In response to the controversy about biological bases of receptivity and mating, James Harlan Elder, in collaboration with Robert M. Yerkes, designed the first truly comprehensive study of factors influencing sexual behavior of chimpanzees. At that time, other persons interested in this problem were employing experimental methods, but Elder's and Yerkes' program most directly addressed the problems confounding prior study and their work served as a model of experimental research into factors affecting receptivity and mating of infrahuman primates.
Assuntos
Comportamento Sexual Animal , Animais , História do Século XX , Primatas , Especificidade da Espécie , Estados UnidosAssuntos
Dieta , Métodos Epidemiológicos , Neoplasias/epidemiologia , Neoplasias da Mama/epidemiologia , Inquéritos sobre Dietas , Gorduras na Dieta/administração & dosagem , Abastecimento de Alimentos , Humanos , Neoplasias Pulmonares/epidemiologia , Estudos Prospectivos , Risco , Fumar , Vitamina A/administração & dosagemRESUMO
Epidemiological interview studies examining the association between vitamin A and cancer at various sites have been hampered by restricted time available for interview; consequently, studies have included varying lists of food items or broad food groups, thus making comparability of results difficult. To identify a standardized list of indicator foods that adequately assess total vitamin A intake, we examined the 24-hour dietary recall of 13,201 adults who participated in the First National Health and Nutrition Examination Survey (NHANES I) from 1971 to 1974. Food items reportedly consumed were ranked by contribution to overall (aggregated) intake in various subpopulations by an index of vitamin A contribution, which reflected the frequency of consumption, portion size, and vitamin A concentration (IUs/100 g). A comparison of these ranks identified certain food items that had a relative contribution to vitamin A intake which varied by sex/race group, season of interview, age, or region of the country; income level had little effect on the food rankings. The top-ranking 50 foods were sufficient to correctly classify 80%-90% of the individuals into low-, moderate-, and high-consumer categories. The major contributing foods for any subpopulation examined included both retinol (e.g., dairy products, liver) and carotenoid sources of vitamin A (e.g., certain fruits and vegetables) in addition to items (e.g., mixed tomato and cheese dishes) not included in earlier questionnaire studies. Recommendations are made for future questionnaires designed to assess vitamin A.
Assuntos
Neoplasias/prevenção & controle , Vitamina A/administração & dosagem , Adolescente , Adulto , Fatores Etários , Idoso , Criança , Pré-Escolar , Etnicidade , Comportamento Alimentar , Humanos , Lactente , Pessoa de Meia-Idade , Inquéritos Nutricionais , Necessidades Nutricionais , Valor Nutritivo , Estações do Ano , Fatores SexuaisRESUMO
A reduced questionnaire was developed by successively omitting segments of the full (98-item) Block questionnaire and calculating the correlations between nutrient estimates produced by the full and reduced versions. The reduced version contains 60 food items and requires 17 minutes to administer by an interviewer. It is intended to capture all nutrients in the diet, as is the full version. The reduced version was validated against three four-day records in a group of middle-aged women, and against two seven-day records collected 10-15 years ago in a group of older men. The absolute value of macronutrients estimated by the reduced questionnaire was lower than food-record estimates, but most micronutrients were not underestimated. For macronutrients correlations with food records were slightly lower with the reduced questionnaire, but for micronutrients there was only slight or no reduction in correlations as a result of using the reduced version. The brief version may be useful in studies that cannot allow the 30-35 minutes required for the full-length questionnaire.